Fig. 2.
MRI spine scans demonstrating complete resolution of leptomeningeal disease at the L4 vertebral with olaparib treatment (T2 weighted, axial sections). a) Enhancing leptomeningeal disease at the L4 vertebral level prior to olaparib. b) Normal appearances at the site of the previous spinal leptomeningeal disease after 6 months of olaparib. c) Normal appearances at the site of the previous spinal leptomeningeal disease after 12 months of olaparib.
